HIV Vaccine

Known as: human immunodeficiency virus vaccine, HIV vaccines, HIV 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The development of stabilized recombinant HIV envelope trimers that mimic the virion surface molecule has increased enthusiasm… (More)
  • figure 2
  • figure 4
  • figure 5
  • figure 6
  • figure 7
Is this relevant?
Review
2015
Review
2015
RV144 remains the only HIV-1 vaccine trial to demonstrate efficacy against HIV-1 acquisition. The prespecified analysis of immune… (More)
  • table 1
  • figure 1
Is this relevant?
2015
2015
An HIV vaccine capable of inducing high and durable levels of broadly neutralizing antibodies has thus far proven elusive. A… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
A successful HIV vaccine will likely induce both humoral and cell-mediated immunity, however, the enormous diversity of HIV has… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Challenge studies following passive immunization with neutralizing Abs suggest that an HIV vaccine could be efficacious were it… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • table II
Is this relevant?
2011
2011
HIV/AIDS continue to devastate populations worldwide. Recent studies suggest that vaccines that induce beneficial immune… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2006
Review
2006
  • Shan Lu
  • Springer Seminars in Immunopathology
  • 2006
A major challenge in developing an HIV vaccine is to identify immunogens and delivery methods that will elicit balanced humoral… (More)
Is this relevant?
2005
2005
Adenovirus 5 (Ad5) vectors show promise as human immunodeficiency virus vaccine candidates. Indian rhesus macaques vaccinated… (More)
Is this relevant?
2002
2002
Preclinical data are reported that support a human immunodeficiency virus (HIV) vaccine strategy using recombinant canarypox-HIV… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
BACKGROUND AND OBJECTIVES The development of a vaccine to prevent human immunodeficiency virus (HIV) infection is a highly… (More)
Is this relevant?